QureTech Bio AB - Company Review
QureTech Bio AB - Company ReviewSummary
QureTech Bio AB (QureTech Bio) is a drug development company that develops antibacterial agents which include broad spectrum activity against Chlamydia and other pathogens, including multi- resistant strains. The company concentrates on developing first line drugs to fight the antibiotic resistance and infectious diseases in the areas of Chlamydia infections. The company’s compounds include virulence blockers, which prevents disease causing properties of multi-resistant bacteria without disrupting the normal bacterial flora, targeting infectious microorganisms. It works in collaboration with Umea University, Washington University and University of Michigan to commercialize their research and innovation. QureTech Bio is headquartered at Umea, Sweden.
This comprehensive company report of QureTech Bio AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.